These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34557068)

  • 21. Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson's disease.
    Chen QQ; Haikal C; Li W; Li MT; Wang ZY; Li JY
    Transl Neurodegener; 2018; 7():13. PubMed ID: 29988485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
    Normando EM; Davis BM; De Groef L; Nizari S; Turner LA; Ravindran N; Pahlitzsch M; Brenton J; Malaguarnera G; Guo L; Somavarapu S; Cordeiro MF
    Acta Neuropathol Commun; 2016 Aug; 4(1):86. PubMed ID: 27535749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
    Park SS; Lee D
    Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal α-Synuclein Aggregates Cause Synaptic- and Microcircuit-Specific Deficits in the Retinal Rod Pathway.
    Xu T; Liu X; Lin X; Xiao J; Zhang D; Ye F; Lu F; Qu J; Zhang J; Chen JF
    Am J Pathol; 2024 May; 194(5):796-809. PubMed ID: 38395146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal α-synuclein deposits in Parkinson's disease patients and animal models.
    Veys L; Vandenabeele M; Ortuño-Lizarán I; Baekelandt V; Cuenca N; Moons L; De Groef L
    Acta Neuropathol; 2019 Mar; 137(3):379-395. PubMed ID: 30721408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stress-enhanced model for discovery of disease-modifying gene: Ece1-suppresses the toxicity of α-synuclein A30P.
    Chen AY; Tully T
    Neurobiol Dis; 2018 Jun; 114():153-163. PubMed ID: 29524599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells.
    Yshii LM; Denadai-Souza A; Vasconcelos AR; Avellar MC; Scavone C
    J Neuroinflammation; 2015 Oct; 12():193. PubMed ID: 26502720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palmitic Acid-Enriched Diet Increases α-Synuclein and Tyrosine Hydroxylase Expression Levels in the Mouse Brain.
    Schommer J; Marwarha G; Nagamoto-Combs K; Ghribi O
    Front Neurosci; 2018; 12():552. PubMed ID: 30127714
    [No Abstract]   [Full Text] [Related]  

  • 32. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
    Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM
    Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease.
    Tan Y; Sgobio C; Arzberger T; Machleid F; Tang Q; Findeis E; Tost J; Chakroun T; Gao P; Höllerhage M; Bötzel K; Herms J; Höglinger G; Koeglsperger T
    Acta Neuropathol; 2020 Feb; 139(2):319-345. PubMed ID: 31768670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
    Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
    Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
    Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
    J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
    Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
    Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.
    Indrieri A; Pizzarelli R; Franco B; De Leonibus E
    Front Neurosci; 2020; 14():567129. PubMed ID: 33192254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
    Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
    Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.